endoASIC has presented his latest research in the field of molecular diagnosis in the 4th International Conference on Bio-Sensing Technology. endoASIC commitment to the future of endoscopy is a smart device equipped with advanced sensing technologies like molecular diagnosis by fluorescence spectroscopy and imaging.
endoASIC has been selected to participate in the EMPENTA III program of ESADECREAPOLIS. The kick-off has been the 14th of January at ESADECREAPOLIS. EMPENTA is financed by ACCIÓ (a Catalan agency that supports competitiveness and promotes innovation and internationalization). The program covers three main areas: shaping team dynamics, developing and validating the business plan, and establishing a financial plan by means of public or private funding.
endoASIC appears today in the special Biotech report of 'La Vanguardia'
endoASIC has successfully finished a contract with IFAE for the consultancy during the design of a new solid-state pixel detector technology for medical imaging. IFAE (Institut de Fisica d'Altes Energies) is an Institute in Catalonia conducting experimental and theoretical research at the frontier of Particle Physics, Astrophysics and Cosmology. IFAE does intensive research on new detectors for medical applications.
Biocat published today in e-news the case of endoASIC, a spin-off of the UB developing chips for endoscopic capsules to diagnose gastrointestinal cancer.
'La Vanguardia', remembering the film of the 60's 'A fantastic voyage', explains in a full page how endoASIC will bring endocopic capsules that move into the intestine controlled from the outside.
endoASIC Technologies starts as spin-off with participation of CIC-UB. The University of Barcelona licenses the technology for the development of the new ASICs of the company.
ENDOASIC Technologies is approved by the social council and government council of the University of Barcelona as spin-off with special mention to the importance of the future activity of ENDOASIC in healthcare sector.
ENDOASIC Technologies presents its business project in the Genoma España investment forum held in Madrid. The event was done in the Instituto de Empresa and gathered 14 projects related to biotechnology.
Bioemprenedor XXI (http://www.bioemprenedorxxi.cat/) is a prestigious entrepreneurship program to assist entrepreneurs in the creation of new start-ups in life sciences. The program is supported by La Caixa, Barcelona Activa, Biocat, Genoma España and the Cambra de Comerç de Barcelona.